Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

The experiment used here shows a method of molecular docking combined with probe technologies to predict and validate the interaction between small molecules of traditional Chinese medicine and protein targets.

Abstract

Deubiquitinating enzymes (DUBs) play a pivotal role in modulating ubiquitination homeostasis, with UCHL3 being an archetypal cysteine DUB intricately involved in a myriad of physiological and pathological processes. Therefore, developing small molecule inhibitors targeting Ubiquitin C-Terminal Hydrolase L3 (UCHL3) is of great significance. This protocol aims to establish a process for virtual screening and in vitro validation of small molecule inhibitors of cysteine DUB represented by UCHL3. Firstly, potential inhibitors of UCHL3 are virtually screened using molecular docking technology, and the interaction between drugs and protein targets is visualized. Subsequently, the effectiveness of the screened drug, Danshensu, is verified through in vitro activity inhibition assays. Ubiquitin-7-amino-4-methylcoumarin (Ub-AMC) and hemagglutinin-ubiquitin-vinyl sulfone (HA-Ub-VS) are used as probes for in vitro activity testing, as they can competitively bind to DUB with small molecule inhibitors to assess the activity of UCHL3. The results indicate that Danshensu has a good binding affinity with UCHL3 in molecular docking, and it can competitively inhibit the activity of UCHL3 with HA-Ub-VS. These findings provide important references for further research and development of therapeutic drugs targeting UCHL3.

Introduction

Ubiquitination is a post-translational modification of proteins, a process by which E1 ubiquitin-activating enzymes, E2 ubiquitin-conjugating enzymes, and E3 ubiquitin ligases attach ubiquitin to the target protein, and the entire process of ubiquitination can be reversed by deubiquitinating enzymes (DUBs)1,2,3,4. Due to their important physiological and pathological role, DUBs are considered important targets for drug discovery5,6.

Over 100 DUBs have been....

Protocol

1. Downloading the structures of small molecules of Salvia miltiorrhiza Bge and the UCHL3

  1. Download the small molecule file.
    1. Open the TCMSP database (https://old.tcmsp-e.com), input danshen (herb name), then press search and click the Radix Salviae in the result list.
    2. Click on download one by one of the items and save the 2D structure in the .mol2 format.<.......

Representative Results

To screen out the small molecules in the Salvia miltiorrhiza Bge that can effectively inhibit UCHL3, we performed molecular docking between the small molecules obtained from the TCMSP website with UCHL3. The top 30 small molecules in the docking results and their scores are shown in Table 1. The docking results for all small molecules are presented in Supplementary Table 1. We selected Danshensu as a representative small molecule for the research. As shown in

Discussion

DUBs play a crucial role in regulating the homeostasis of the entire ubiquitin system by removing ubiquitin from substrates or polyubiquitin chains37. In recent years, these enzymes have also attracted much attention as targets for drug development13. However, there are challenges in the process of small-molecule drug development. For instance, high-throughput screening involving tens of thousands of small molecule libraries results in high costs and a significant workload .......

Acknowledgements

This work was supported by the National Natural Science Foundation of Beijing [grant number 7244498].

....

Materials

NameCompanyCatalog NumberComments
30% AcrylamideBeijing Lablead Biotech Co., LtdA3291
Ammonium persulfateChina National Medicines Corporation Ltd10002616
Anti-rabbit IgG, HRP-linked Antibody #7074Cell Signaling Technology7074P2
BeyoECL PlusBeyotimeP0018S
Bradford Protein Assay KitBeyotimeP0006
ClonExpress Ultra One Step Cloning KitVazymeC115-01
DanshensuShanghai yuanye Bio-Technology Co., LtdB20254
DMSOAmeresco, Inc.21K2356571
Electrophoresis SystemLiuyi Biotechnology112-0630
HEPESSigmaH3375
His-tagged protein purification kit (NTA-Ni agarose magnetic beads)BeyotimeP2247S
Immun-Blot PVDF Membrane, Roll, 26 cm x 3.3 mBio-Rad Laboratories (Shanghai) Co., Ltd1620177
Isopropyl alcoholMacklinI811925
M5 Prestained Protein LadderMei5 Biotechnology Co.LtdMF-212-01
MaestroSchrödinger’shttps://www.schrodinger.com/platform/products/maestro/
Methyl alcoholChina National Medicines Corporation Ltd10014108
MF-MilliporeMilliporeHAWP04700
MyFug mini centrifugeSigmaZ764183
Pierce Dilution-Free Rapid Gold BCA Protein AssayThermo ScientificA55860
PR-619Cell Signaling Technology26065S
Primary Antibody Dilution Buffer for Western BlotMacklinP917820
Recombinant Human HA-Ubiquitin Vinyl Sulfone Protein, CFR&D SystemsU-212-025
Recombinant Human Ubiquitin AMC Protein, CFR&D SystemsU-550-050
Skim MilkBecton,Dickinson and Company232100
Sodium Dodecyl Sulfate (SDS)Ameresco, Inc.205-788-1
TEMEDAmeresco, Inc.2545C134
Tween 20Beijing Lablead Biotech Co., Ltd0777-1
UCHL3 (D25E6) Rabbit mAbCell Signaling Technology8141T

References

  1. Ciechanover, A. The ubiquitin proteolytic system and pathogenesis of human diseases: A novel platform for mechanism-based drug targeting. Biochem Soc Trans. 31 (2), 474-481 (2003).
  2. Schulman, B. A., Harper, J. W.

Explore More Articles

Medicine

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved